Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Beglinger

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Gut|April 1, 1991
Helicobacter pylori infection in healthy people: a dynamic process?B Meyer, B Werth, C Beglinger, et al.
Revue Medicale Suisse|August 25, 2006
[Infliximab--practical guidelines for the treatment of Crohn's disease]P Bauerfeind, C Beglinger, J Beltinger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 20, 2004
Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of DiabetesL Rossi, S Parvin, Z Hassan, et al.
Scandinavian Journal of Gastroenterology|April 1, 1988
Reduction in early recurrence of variceal bleeding by propranololU A Marbet, A Straumann, K E Gyr, et al.
Gastroenterology|August 1, 1991
Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumideM Fried, U Erlacher, W Schwizer, et al.
Digestion|October 12, 2000
Helicobacter pylori and gastric erosions. Results of a prevalence study in asymptomatic volunteersF S Lehmann, E L Renner, B Meyer-Wyss, et al.
Gut|October 16, 2009
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialA Straumann, S Conus, P Grzonka, et al.
Gut|October 14, 2004
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineW Kruis, P Fric, J Pokrotnieks, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohortV Pittet, P Juillerat, P Michetti, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2001
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humansC Verdich, A Flint, J P Gutzwiller, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Gut|April 1, 1991
Helicobacter pylori infection in healthy people: a dynamic process?B Meyer, B Werth, C Beglinger, et al.
Revue Medicale Suisse|August 25, 2006
[Infliximab--practical guidelines for the treatment of Crohn's disease]P Bauerfeind, C Beglinger, J Beltinger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 20, 2004
Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of DiabetesL Rossi, S Parvin, Z Hassan, et al.
Scandinavian Journal of Gastroenterology|April 1, 1988
Reduction in early recurrence of variceal bleeding by propranololU A Marbet, A Straumann, K E Gyr, et al.
Gastroenterology|August 1, 1991
Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumideM Fried, U Erlacher, W Schwizer, et al.
Digestion|October 12, 2000
Helicobacter pylori and gastric erosions. Results of a prevalence study in asymptomatic volunteersF S Lehmann, E L Renner, B Meyer-Wyss, et al.
Gut|October 16, 2009
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialA Straumann, S Conus, P Grzonka, et al.
Gut|October 14, 2004
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineW Kruis, P Fric, J Pokrotnieks, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohortV Pittet, P Juillerat, P Michetti, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2001
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humansC Verdich, A Flint, J P Gutzwiller, et al.
Pageof 28